Adherex Enrolls First Patient in Clinical Trial For Metastatic Breast Cancer
In 2010, NCI estimated that 207,090 women were diagnosed with breast cancer, while 39,840 women likely died from the disease.
Articles by Herina Ayot
Fertility Focus Improves Diagnoses and Treatment of Infertility
Infertility is one of the most impacting and daunting conditions in Women’s Health medicine, afflicting approximately 10% of the female population. To address this condition, […]
Insituvue To Present X-Ray Technology At OneMedForum NY 2011
Insituvue is preparing to commercialize the Sonic Flashlight technology, a device developed at University of Pittsburgh that gives medical professionals a better view during procedures.
It’s So Hard To Say Goodbye: The Exit Strategy
Parting is such sweet sorrow when building a company from infancy and then letting go to see it spread its wings. Planning a proper exit strategy is crucial and not just when referring to love and war.
QR Pharma Returns to OneMedForum To Present Alzheimer’s Technology
OR Pharma previously presented at OneMedForum San Francisco and will return in June to preset their technology at OneMedForum NY 2011.
CeQur Develops Diabetes Compliance Device
An important drawback of current diabetes treatment regimens is patient compliance, particularly for insulin injections that are painful and must also be timely administered.
Accord Biosciences To Present At OneMedForum NY 2011
Nitric oxide is one of the most important physiological signaling molecules in the body, responsible for regulating such fundamental biological processes as proper blood vessel function and the body’s defense against infection.
Del Mar Pharmaceuticals Is Fighting Cancer One Molecule At A Time
Del Mar Pharmaceuticals was recently added to the roster of presenting companies at OneMedForum NY 2011.
MEDomics to Present At OneMedForum NY 2011
OneMedForum NY 2011 welcomes MEDomics, LLC, a molecular diagnostic laboratory, confirmed to present in June at the annual conference.
Aduro Biotech, OneMedForum SF Presenting Company, Announces $20 Million Financing
Aduro BioTech, a OneMedForum presenting company is engineering Listeria to treat Pancreatic Cancer and other infectious diseases.